secretagogue

(redirected from secretagogues)
Also found in: Medical.

se·cre·ta·gogue

 (sĭ-krē′tə-gôg′, -gŏg′)
n.
A hormone or another agent that causes or stimulates secretion.

secretagogue

(sɪˈkriːtəɡɒɡ)
n
(Medicine) med a substance that stimulates secretion
seˌcretaˈgogic adj
Translations

se·cre·ta·gogue

, secretogogue
n. secretogogo, agente que estimula la secreción glandular.
References in periodicals archive ?
13) In these methods, piezoelectric lithotripter is used to deliver a shock wave and reduce calculi to small fragments that are then flushed out of the duct with spontaneous salivation or the use of secretagogues.
Historically, type 2 diabetes was treated with non-insulin medications aimed at reducing hyperglycemia and insulin resistance, such as insulin secretagogues, insulin sensitizers, and drugs that impair absorption of ingested carbohydrates.
However, alcohol consumption may increase the risk of delayed hypoglycaemia, especially in persons on insulin or insulin secretagogues.
Patients taking metformin, short-acting insulin secretagogues, sulphonylureas drugs or insulin will need to make adjustments to dose and or timings to reduce the risk of hypoglycemia while maintaining good glycemic control," the endocrinologist said.
Shuler, BS, DDS, CCN, LN, is involved in immunoncology for the prevention and treatment of cancer, human growth hormone secretagogues, and osteoporosis.
So recently growth hormone secretagogues are discovered which provide a more physiological route for the release of growth hormone8.
When choosing additional pharmacologic interventions to improve glycemic control in overweight or obese patients, providers should use medications that promote weight loss or are weight neutral such as metformin, sodium-glucose cotransporter--2 (SGLT-2) inhibitors, glucagonlike peptide--1 (GLP-1) agonists, and dipeptidyl peptidase--4 inhibitors (DPP-4) versus those that cause weight gain such as insulin secretagogues, thiazolidinediones, and insulin.
A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.
Modified from Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the international dry eye workshop (2007) (1) Table 2 Level Treatment 1 Education and environmental/dietary modifications Elimination of offending systemic medications Artificial tear substitutes, gels/ointments Eyelid therapy 2 If level 1 treatments are inadequate, add: Anti-inflammatories Tetracyclines (for meibomianitis) Punctal plugs Secretagogues Moisture chamber spectacles 3 If level 2 treatments are inadequate add: Serum Contact lenses Permanent punctal occlusion 4 If level 3 treatments are inadequate add: Systemic anti-inflammatory agents Surgery
Additional data will be added, such as existing studies on acute response to intravenous beta-cell secretagogues, and functional genomics on human islets, liver, muscle and adipose tissue, to maximise the power and utility of an innovative integrated biology approach.
Sulphonylureas are the insulin secretagogues drugs acts via K+-ATP channel dependent way, where glucose metabolism in pancreatic A3/4 cells increases intracellular ATP/ADP ratio and leads to closure of K+-ATP channels.
1 U/kg per day of glargine or continuation of oral agents (metformin, insulin secretagogues, thiazolidinediones, or DPP-4 inhibitors).
Full browser ?